The National Comprehensive Cancer Network (NCCN) has published new NCCN Guidelines for Patients: Marginal Zone Lymphoma. A cancer of the lymphatic system, marginal zone lymphoma (MZL) is a type of non-Hodgkin B-cell lymphoma ...
Sep 12, 2022
0
6
President Joe Biden will evoke John F. Kennedy's famous 1962 speech on putting an American on the moon next week when he outlines his government's goal of halving cancer deaths, the White House said Wednesday.
Sep 7, 2022
0
17
Liver cancer's rapid growth leads to a vulnerability in its energy-production and cell-building processes that may be potently exploited with a new combination-treatment strategy, according to a study from researchers at ...
Aug 2, 2022
0
72
A diverse and well-prepared leadership workforce in the nation's cancer centers is vital to tackle challenges in the delivery of equitable cancer care delivery. Recognizing this, the Association of American Cancer Institutes ...
Jul 28, 2022
0
1
Experts from Cedars-Sinai Cancer have analyzed patient samples, along with studies conducted in animal models, to identify a novel immune checkpoint pathway to treat hepatocellular carcinoma, the most common form of liver ...
Jun 20, 2022
0
108
Screening mammography volumes have not returned to pre-COVID-19 levels, according to a study published online June 8 in the Journal of the American College of Radiology.
Jun 10, 2022
0
5
In a small but multi-institutional study, an artificial intelligence-based system improved providers' assessments of whether patients with bladder cancer had complete response to chemotherapy before a radical cystectomy (bladder ...
Apr 22, 2022
0
43
At first blush, the numbers aren't great: Cancer patients who are covered by Medicaid tend to have later-stage disease and higher rates of mortality.
Apr 14, 2022
0
3
Scientists from Vanderbilt-Ingram Cancer Center (VICC) collaborated with researchers from New York to determine that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk ...
Mar 7, 2022
0
63
A new study—in mice—from Washington University School of Medicine in St. Louis suggests that blocking a major inflammatory pathway that is activated in pancreatic cancer makes the tumors sensitive to chemotherapy and ...
Mar 7, 2022
0
49
